title: Interleukin-1 beta-induced effects on plasma oxytocin and arginine vasopressin: role of adrenal steroids and route of administration.
abstract: The effects of cytokines in stimulating neurohypophysial hormone release have not been well characterized. In the present study, we have investigated the effect of intraperitoneal injection of recombinant human interleukin (IL)-1 beta on oxytocin release in sham-operated controls, adrenalectomized (ADX) rats and ADX rats given either low or high doses of the synthesis glucocorticoid dexamethasone. In a second study, we determined the effect of central injection of IL-1 beta on both oxytocin and arginine vasopressin (AVP) release in sham-operated and ADX rats. We were unable to demonstrate an increase in plasma oxytocin in intact rats in response to intraperitoneal injection of IL-1 beta. In contrast, we found a substantial and sustained increase in plasma oxytocin concentrations in ADX rats. This stimulation was abolished by treatment with dexamethasone at both the low and high doses. Following central injection of IL-1 beta, we were unable to demonstrate any increase in either oxytocin or AVP, despite the ability of this dose of cytokine to stimulate the hypothalamo-pituitary-adrenal axis, as evidenced by increased circulating corticosterone. It appears that circulating glucocorticoids may exert a tonic inhibitory effect on the release of oxytocin in response to peripheral stimulation by IL-1 beta.
authors.affiliation: University Department of Medicine, Bristol Royal Infirmary, UK. M.S.Harbuz@bris.ac.uk
authors.forename: M S
authors.initials: MS
authors.lastname: Harbuz
authors.forename: A J
authors.initials: AJ
authors.lastname: Chover-Gonzalez
authors.forename: G L
authors.initials: GL
authors.lastname: Conde
authors.forename: D
authors.initials: D
authors.lastname: Renshaw
authors.forename: S L
authors.initials: SL
authors.lastname: Lightman
authors.forename: D S
authors.initials: DS
authors.lastname: Jessop
mesh_terms: D000305:Adrenal Cortex Hormones / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood* / Q000187:drug effects* / Q000378:metabolism; D003345:Corticosterone / Q000097:blood; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology; D004333:Drug Administration Routes; D006801:Humans; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D007375:Interleukin-1 / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009994:Osmolar Concentration; D010121:Oxytocin / Q000097:blood* / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D000305:Adrenal Cortex Hormones; D007375:Interleukin-1; D011994:Recombinant Proteins; D001127:Arginine Vasopressin; D010121:Oxytocin; D003907:Dexamethasone; D003345:Corticosterone